Literature DB >> 16521204

A case of successful management with splenectomy of intractable ascites due to congenital dyserythropoietic anemia type II-induced cirrhosis.

Themistoklis Vassiliadis1, Vassilia Garipidou, Vassilios Perifanis, Konstantinos Tziomalos, Olga Giouleme, Kalliopi Patsiaoura, Michalis Avramidis, Nikolaos Nikolaidis, Sofia Vakalopoulou, Ioannis Tsitouridis, Antonios Antoniadis, Panagiotis Semertzidis, Anna Kioumi, Evangelos Premetis, Nikolaos Eugenidis.   

Abstract

The congenital dyserythropoietic anemias comprise a group of rare hereditary disorders of erythropoiesis, characterized by ineffective erythropoiesis as the predominant mechanism of anemia and by characteristic morphological aberrations of the majority of erythroblasts in the bone marrow. Congenital dyserythropoietic anemia type II is the most frequent type. All types of congenital dyserythropoietic anemias distinctly share a high incidence of iron loading. Iron accumulation occurs even in untransfused patients and can result in heart failure and liver cirrhosis. We have reported about a patient who presented with liver cirrhosis and intractable ascites caused by congenital dyserythropoietic anemia type II. Her clinical course was further complicated by the development of autoimmune hemolytic anemia. Splenectomy was eventually performed which achieved complete resolution of ascites, increase of hemoglobin concentration and abrogation of transfusion requirements.

Entities:  

Mesh:

Year:  2006        PMID: 16521204      PMCID: PMC4066141          DOI: 10.3748/wjg.v12.i5.818

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  34 in total

1.  Comparative response to splenectomy in Coombs-positive autoimmune hemolytic anemia with or without associated disease.

Authors:  G Akpek; D McAneny; L Weintraub
Journal:  Am J Hematol       Date:  1999-06       Impact factor: 10.047

2.  Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques.

Authors:  H L Bonkovsky; R B Rubin; E E Cable; A Davidoff; T H Rijcken; D D Stark
Journal:  Radiology       Date:  1999-07       Impact factor: 11.105

Review 3.  The role of surgery in the treatment of portal hypertension.

Authors:  D A Iannitti; J M Henderson
Journal:  Clin Liver Dis       Date:  1997-05       Impact factor: 6.126

Review 4.  The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.

Authors:  Thomas D Boyer; Ziv J Haskal
Journal:  Hepatology       Date:  2005-02       Impact factor: 17.425

5.  Molecular medicine and hemochromatosis: at the crossroads.

Authors:  B R Bacon; L W Powell; P C Adams; T F Kresina; J H Hoofnagle
Journal:  Gastroenterology       Date:  1999-01       Impact factor: 22.682

6.  HFE genotype in patients with hemochromatosis and other liver diseases.

Authors:  B R Bacon; J K Olynyk; E M Brunt; R S Britton; R K Wolff
Journal:  Ann Intern Med       Date:  1999-06-15       Impact factor: 25.391

7.  A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites.

Authors:  M Rössle; A Ochs; V Gülberg; V Siegerstetter; J Holl; P Deibert; M Olschewski; M Reiser; A L Gerbes
Journal:  N Engl J Med       Date:  2000-06-08       Impact factor: 91.245

8.  Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register.

Authors:  B Modell; M Khan; M Darlison
Journal:  Lancet       Date:  2000-06-10       Impact factor: 79.321

9.  Hereditary hemochromatosis in a patient with congenital dyserythropoietic anemia.

Authors:  S Fargion; L Valenti; A L Fracanzani; M Sampietro; M D Cappellini; A Scaccabarozzi; D Soligo; C Mariani; G Fiorelli
Journal:  Blood       Date:  2000-11-15       Impact factor: 22.113

10.  Successful management of concurrent congenital dyserythropoietic anaemia and autoimmune haemolytic anaemia with splenectomy.

Authors:  M L Schmidt; S Joshi; P J DeChristopher; M Mihalov; S D Sosler
Journal:  Br J Haematol       Date:  1998-09       Impact factor: 6.998

View more
  1 in total

Review 1.  Optimal management strategies for chronic iron overload.

Authors:  James C Barton
Journal:  Drugs       Date:  2007       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.